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1. Introduction 
The scope of this chapter is to examine how advances in the field of Bioinformatics can be 
applied in the development of improved therapeutic strategies. In particular, we focus on 
how algorithms designed to unravel complex gene regulatory networks can then be used in 
the design of synthetic gene promoters that can be subsequently incorporated in novel gene 
transfer vectors to promote safer and more efficient expression of therapeutic genes for the 
treatment of various pathological conditions. 
2. Development of synthetic promoters: a historical perspective 
A synthetic promoter is a sequence of DNA that does not exist in nature and which has been 
designed to control gene expression of a target gene. Cis-regulatory sequences derived from 
naturally-occurring promoter elements are used to construct these synthetic promoters 
using a building block approach; which can either be carried out by rational design or by 
random ligation (illustrated in figure 1A). The result is a sequence of DNA composed of 
several distinct cis-regulatory elements in a completely novel orientation that can act as a 
promoter enhancer; typically to initiate RNA polymerase II-mediated transcription. 
Construction of synthetic promoters is possible because of the modular nature of naturally-
occurring gene regulatory regions. This was cleverly demonstrated by a group that used 
synthetic promoters to evaluate the role of the TATA box in the regulation of transcription 
(Mogno et al., 2010). The authors looked at the role of the TATA box in dictating the 
strength of gene expression. They found that the TATA box is a modular component in that 
its strength of binding to the RNA polymerase II complex and the resultant strength of 
transcription that it mediates is independent of the cis-regulatory element enhancers 
upstream. Importantly, they also found that the TATA box does not add noise to 
transcription, i.e. it acts as a simple amplifier without altering specificity of gene expression 
dictated by the upstream enhancer elements. Thus implying that any combination of cis-
regulatory enhancers could be coupled to a TATA box and it would be the enhancers that 
would mediate specificity without any interference from the TATA box. The implications 
from this study suggest that it should be possible to construct any type of synthetic 
promoter that is specifically engineered to display a highly restrictive pattern of gene 
regulation. 
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Synthetic promoters have been used in the study of gene regulation for more than two 
decades. In one of the first examples a synthetic promoter derived from the lipoprotein gene 
in E. Coli was used to efficiently drive the expression of a number of tRNA genes (Masson et 
al., 1986). In the years that followed a technique was developed that enabled the mutation of 
prokaryotic sequences flanking the essential -10 and -35 promoter elements (illustrated in 
figure 1B) and thus the efficient construction of synthetic promoters for use in bacteria 
(Jacquet et al., 1986). This approach was successfully used to produce promoters with much 
higher activity compared to naturally occurring sequences and it was immediately realised 
that such an approach would have important applications in the biotech industry, 
particularly in the enhanced production of biopharmaceuticals (Trumble et al., 1992). 
 
A. Typical Mammalian Synthetic Promoter Layout
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Fig. 1. Typical synthetic promoter layouts for prokaryotes and eukaryotes 
Most of these studies were initially undertaken with a view to establish the important 
structural features of prokaryotic or eukaryotic promoters so that essential elements could 
be identified. In one example, the role of the Tat protein in the regulation of HIV gene 
expression was studied using synthetic promoters (Kamine et al., 1991). In this study a series 
of minimal promoters containing Sp1- binding sites and a TATA box were constructed and 
analysed to see if the Tat protein from HIV could activate them. The results demonstrated 
that Tat could only activate the synthetic promoters containing Sp1 sites and not promoters 
with the TATA box alone. The observations enabled the authors to propose that in vivo the 
Tat protein is brought to the promoter site by TAR RNA and then interacts with Sp1 to drive 
gene expression. In recent years more sophisticated studies using synthetic promoters have 
been undertaken to evaluate the important factors driving transcription factor binding to 
their corresponding cis-regulatory elements (Gertz et al., 2009a) and to thermodynamically 
model trans-factor and cis-element interactions (Gertz et al., 2009b). 
As alluded to above, it was soon realised that synthetic promoter technology had direct 
implications in the improvement of the efficiency of gene expression. Indeed, one of the 
most widely used eukaryotic promoters employed for research purposes today is actually a 
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synthetic promoter. The steroid-inducible Glucocorticoid Receptor Element (GRE) is a 
naturally occurring sequence that regulates the expression of a plethora of genes that are 
responsive to glucocorticoids. In a relatively early study several of these elements were 
linked together in order to construct a promoter with enhanced responsiveness to these 
steroids (Mader et al., 1993). This study detailed the construction of a 5 x GRE synthetic 
promoter linked to the Adenovirus type 2 major late promoter TATA region that displayed 
50-fold more expression levels in response to steroid hormones when compared to the 
natural promoter sequence. This synthetic promoter is now a widely used constituent of a 
number of reporter constructs adopted in a variety of different research applications. 
Finally, synthetic promoters have also been used in prokaryotic systems to reveal that 
regulation of gene expression follows boolean logic (Kinkhabwala et al., 2008). In this 
prototypical study the authors found that two transcription repressors generate a NOR 
logic; i.e. a OR b (on OR off), while one repressor plus one activator determines an ANDN 
logic; i.e. a AND NOT b (on AND NOT off). This idea was later expanded on to demonstrate 
that various combinations of synthetic promoters could combine to generate 12 out of 16 
boolean logic terms (Hunziker et al., 2010). Most interestingly the results from these studies 
demonstrated that if a promoter does not follow a specific logic it is more likely to be leaky, 
in that it will drive gene expression under conditions where it is not expected to. 
In this chapter we describe the evolution of synthetic promoter technology, its application in 
the development of improved tissue-specific promoters and its potential use for the 
development of effective disease-specific gene regulators; thus enabling the development of 
safer and more effective gene therapies. 
3. Recent advances in the design of the synthetic promoter 
In recent years some efforts have been made to construct synthetic promoters for tissue 
specific transcription based on the linking of short oligonucleotide promoter and enhancer 
elements in a random (Li et al., 1999; Edelman et al., 2000) or ordered (Chow et al., 1997; 
Ramon et al., 2010) fashion. 
In what can be described as one of the first attempts to rationally design a tissue-specific 
synthetic promoter, Chow et al. describe the rearrangement of the cytokeratin K18 locus to 
construct a promoter mediating a highly restrictive pattern of gene expression in the lung 
epithelium (Chow et al., 1997). In this study the authors describe the generation of 
transgenic mice with this construct and demonstrate expression only in the lung. They also 
generated CMV (Cytomegalovirus) and SV40 (Sarcoma Virus 40) promoter based constructs 
and found lack of specificity and no expression in the lung epithelia. This study had 
important implications for researchers developing lung-based gene therapies, i.e. if CMV, 
one of the most widely used promoters, could not regulate gene expression in the lung 
epithelia then it is necessary to identify (or develop) new promoters that can efficiently 
regulate gene expression in this location. Indeed, it is now becoming increasingly apparent 
that traditional virus-derived promoters like CMV and RSV (Rous Sarcoma Virus) will have 
limited application in the development of modern gene therapeutics. 
The random assembly of cis-regulatory elements has shown particular success as a means to 
develop synthetic promoters. In one such approach, which aimed to identify synthetic 
promoters for muscle-specific expression, duplex oligonucleotides from the binding sites of 
muscle-specific and non-specific transcription factors were randomly ligated and cloned 
upstream of a minimal muscle promoter driving luciferase (Li et al. 1999). Approximately 
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1000 plasmid clones were individually tested by transient transfection into muscle cells and 
luciferase activity was determined in 96-well format by luminometry. By this approach 
several highly active and muscle specific promoters were identified that displayed 
comparable strength to the most commonly used viral promoters such as CMV. 
 
 
Fig. 2. Typical procedure for generation of synthetic mammalian promoters (reproduced 
from PNAS, Vol. 97, No. 7, pp. 3038-3043 copyright (c) 2000 by the National Academy of 
Sciences, USA) 
Retroviral vectors have also been used to screen for synthetic promoters in eukaryotic cells 
(Edelman et al., 2000). This study was the first description of a retroviral library approach 
using antibiotic resistance and FACS selection to isolate promoter sequences (illustrated in 
figure 2). The libraries generated using random oligonucleotides in an effort to identify new 
sequences as well as examining the effects of combinations of known elements and for 
uncovering new transcriptional regulatory elements. After preparing a Ran18 promoter 
library comprises random 18mer oligonucleotides, the authors analysed the sequences of the 
generated synthetic promoters by searching for known transcription factor binding motifs. 
They found that the highest promoter activities were associated with an increased number 
of known motifs. They examined eight of the best known motifs; AP2, CEBp, gre, ebox, ets, 
creb, ap1 AND sP1/maz. Interestingly, several of the promoter sequences contained none of 
these motifs and the author's looked for new transcription factors. 
In a similar effort employed to examine one million clones, Sutton and co-workers adopted 
the FACS screening approach based on the establishment of a lentiviral vector-based library 
(Dai et al., 2004). In this study duplex oligonucleotides from binding sites of endothelial cell-
specific and non-specific transcription factors were cloned in a random manner upstream of 
a minimal promoter driving expression of eGFP in a HIV self-inactivating expression vector. 
A pool of one million clones was then transfected into endothelial cells and the highest 
www.intechopen.com
 
The Use of Functional Genomics in Synthetic Promoter Design 
 
379 
expressers were selected by FACS sorting. Synthetic promoters were then rescued from 
stable transfectants by PCR from the genomic DNA where the HIV vectors had integrated. 
The results from this study also demonstrated the possibility of isolating several highly 
active endothelial cell-specific synthetic promoter elements from a random screen. 
Synthetic promoters active only in the liver have also been developed (Lemken et al., 2005). 
In this study transcriptional units from ApoB and OTC genes were used in a controlled, 
non-random construction procedure to generate a series of multimeric synthetic promoters. 
Specifically, 2x, 4x, 8x and 16x repeats of the ApoB and OTC promoter elements were 
ligated together and promoter activity analysed. The results indicated that the promoter 
based on 4xApoB elements gave the optimal levels of gene expression and that 8x and 16x 
elements gave reduced levels of expression, thus demonstrating the limitations of simply 
ligating known promoter elements together in a repeat fashion to achieve enhanced 
expression. 
When adopting this type of methodology in the design of synthetic tissue-specific promoters 
it is important to use well-designed duplex oligonucleotides. For example, each element has 
to be spaced in such a way that the regulatory elements appear on the same side of the DNA 
helix when reassembled, relevant minimal promoter elements have to be employed so that 
the screen produces promoters capable of expressing efficiently only in the tissue of interest 
and there must be some sort of mechanism, such as the addition of Sp1 sites, for the 
protection against promoter silencing through methylation. 
In addition to tissue-specific promoters, cell-type synthetic promoters have also been 
developed. In one study, researchers designed a synthetic promoter to be active in 
nonadrenergic (NA) neurones (Hwang et al., 2001). They authors randomly ligated cis-
regulatory elements that were identified from the human dopamine beta-hydroxylase 
(hDBH) gene and constructed promoters with up to 50-fold higher activity than the original 
promoter. Specifically, two elements from the promoter were used to generate a multimeric 
synthetic promoter; PRS1 and PRS2 which are bound to by the Phox2a transcription factor. 
The results demonstrated that the PRS2 was responsible for higher levels of gene expression 
as it had higher affinity to Phox-2a. It was also found that eight copies of PRS2 in the same 
orientation yielded maximum activity. 
In a similar type of study a synthetic promoter was constructed that was specifically active 
in myeloid cells (He et al., 2006). The promoter comprised myeloid-specific elements for 
PU.1, C/EBPalpha, AML-1 and myeloid-associated elements for Sp1 and AP-1, which were 
randomly inserted upstream of the p47-phox minimal promoter. Synthetic promoters 
constructed showed very high activity. Haematopoietic Stem Cells (HSC) were initially 
transduced then the expression in differentiated cells was examined; only myeloid cells 
were found to express the reporter construct. To test therapeutic applicability of these 
promoters apoE-/- mice were transplanted with HSC transduced with a lentiviral vector 
expressing apoE from CMV and synthetic promoters. Even though transduced cells 
containing CMV and synthetic promoters both corrected the artherosclerotic phenotype, the 
cells derived from lentiviral vectors harbouring the synthetic promoter did so with less 
variability. Thus highlighting the improved safety features when using synthetic promoters 
for gene therapy applications. 
In addition to tissue- and cell type-specific constitutive promoters, inducible synthetic 
promoters can also be constructed. One group describe a synthetic promoter constructed by 
placing the EPO enhancer region upstream of the SV40 promoter. The result is a strong 
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promoter that is active only under ischaemic conditions. The authors tested this promoter by 
developing Neural Stem Cells (NSC) responsive to hypoxia and proposed that this system 
could be used to deliver therapeutic stem cells to treat ischaemic events. The authors were 
able to demonstrate that transplantation of NSC modified with a hypoxia-sensitive synthetic 
promoter resulted in specific expression of the luciferase reporter gene in response to 
ischaemic events in vivo (Liu et al., 2010). 
4. Applications of synthetic promoter technology 
Synthetic promoters have direct applications in large-scale industrial processes where 
enzymatic pathways are used in the production of biological and chemical-based products 
(reviewed in Hammer et al., 2006). One of the most important limitations in industrial-scale 
processes that synthetic promoter technology addresses is the inherent genetic instability in 
synthetically engineered biological systems. For instance, in prokaryotic organisms designed 
to express two or more enzymes, mutations will invariably arise in very few generations 
resulting in the termination of gene expression. This is because there is the lack of 
evolutionary pressure keeping all the components intact. The result is that mutations accrue 
over generations resulting in the deactivation of the circuit. Homologous recombination in 
natural promoters driving high levels of gene expression is the main reason why this 
circuitry fails (Sleight et al., 2010). Therefore, the use of synthetic promoters in these systems 
should serve to lower gene expression to result in more genetic stability, allow the 
avoidance of repeat sequences to prevent recombination and allow the use inducible 
promoters (a feature that also reduces genetic instability). In summary, the use of synthetic 
promoter technology in complex genetically engineered synthetic organisms expressing a 
variety of components should serve to increase genetic stability and improve the efficiency 
of the processes that the components control. 
One interesting therapeutic application for synthetic promoter technology that has been 
described is the generation of a class of replication-competent viruses that enable tumour 
cell-specific killing by specifically replicating in cancer cells. In this study a replication 
competent retrovirus was developed to selectively kill tumour cells (Logg et al., 2002). The 
authors added a level of transcriptional targeting by incorporating the prostate-specific 
probasin (PB) promoter into the retroviral LTR and designed more efficient synthetic 
promoters based on the PB promoter to increase the efficiency of retroviral replication in 
prostate cancer cells. The result was a retrovirus that could efficiency transduce and 
replicate only in cancer cells. This is an attractive therapeutic strategy for the treatment of 
cancer, as tumour virotherapy has actually been examined as a potential therapeutic 
strategy for several decades. 
Synthetic promoters that are active only in cycling endothelial cells would be another 
attractive tool for the development of cancer gene therapies. The rationale being that by 
targeting new blood vessels growing into tumours we would be able to develop a cancer 
gene therapy that could cut off supply of nutrients to the growing cancer. In a study that 
adopted this approach the cdc6 gene promoter was identified as a candidate promoter 
active only in cycling cells and was coupled to the endothelin enhancer element to construct 
a promoter active in dividing endothelial cells (Szymanski et al., 2006). Four endothelin 
elements conjugated to the cdc6 promoter gave the optimal results in vitro. When introduced 
into tumour models in vivo, the synthetic promoter was more efficient at driving gene 
expression in cancerous tissues, when compared to a CMV promoter. 
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Perhaps one of the most impressive applications of synthetic promoter technology thus far 
was the development of a liver-specific promoter that could be used to essentially cure 
diabetes in a transgenic mouse model (Han et al., 2010). In this study a synthetic promoter 
active in liver cells in response to insulin was constructed. The authors designed 3-, 6- & 9-
element promoters based on random combinations of HNF-1, E/EBP and GIRE cis-elements. 
In the 3-element promoters all 27 combinations of the three were tested and the highest 
activity promoters were used to generate the 6-element promoter and so on. Using this 
technique promoters with activity up to 25% of CMV were identified. Finally, the optimal 
promoter was chosen depending on its responsiveness to glucose. This promoter showed 
highest specificity to liver cells and in response to Glucose and yielded expression levels 
21% that of CMV. Adenoviral vectors containing this promoter driving expression of insulin 
were injected into a mouse diabetic model. Injection with the highest dose of virus resulted 
in protection against hyperglycaemia for 50 days. Importantly, injection with adenovirus 
expressing insulin from a CMV promoter resulted in death of the animals due to 
hypoglycaemia, thus illustrating the importance of regulated expression in gene therapy. 
Importantly, the results from this study excellently illustrated why the clever design of 
synthetic promoters controlling restricted gene expression will be essential in the 
development of safe gene therapy. 
Synthetic promoters are increasingly being used in gene therapy type of studies. In one 
recent study their potential application to the gene therapy of Chronic Granulomatous 
Disease (X-CGD; an X-linked disorder resulting from mutations in gp91-phox, whose 
activity in myeloid cells is important in mounting an effective immune response) was 
examined (Santilli et al., 2011). The authors cite a clinical trial using a retroviral vector, 
which was successful at correcting the phenotype, but expression was short-lived due to 
promoter inactivation. In order to address this issue a chimeric promoter was constructed 
that was a fusion of Cathepsin G and c-Fes minimal promoter sequences, which are 
specifically active in cells of the myeloid lineage. This promoter was used to drive the 
expression of gp91-phox in myeloid cells in mice using a SIN lentiviral vector and the 
results show effective restricted expression to monocytes and subsequent introduction of 
gp91 results in high levels of expression in target cells and restoration of wild type 
phenotype in vitro. X-CGD cells were then transduced with the lentiviral vector and grafted 
into a mouse model of CGD. The vector was able to sustain long-term expression of gp91-
phox, resulting in levels of expression that could correct the phenotype. Expression was 
specifically seen in granulocytes and monocytes, and not B- and T-cells. 
These studies serve to highlight the potential application of synthetic promoter technology 
in gene therapy. They particularly highlight the importance of achieving cell-type specific 
gene expression and address the common issue of promoter shutdown that is seen when 
using stronger viral promoters like those derived from the CMV and RSV. If gene therapy is 
to be a success in the clinic it will be imperative to develop promoters that are highly 
specific and which display a restrictive and predictable expression profile. Thus, synthetic 
promoter technology represents the ideal solution to achieve this goal and its use is likely to 
become an increasingly popular approach adopted by researchers developing gene 
therapeutics. 
5. Bioinformatic tools and synthetic promoter development 
We first described how functional genomics experimentation and bioinformatics tools could 
be applied in the design of synthetic promoters for therapeutic and diagnostic applications 
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several years ago (Roberts, 2007). Since then a number of scientists have also realised that 
this approach can be broadly applied across the biotech industry (Venter et al., 2007). In this 
section we discuss some of the tools that we use to analyse data obtained from large-scale 
gene expression analyses, which is subsequently used in the smart design of synthetic 
promoters conveying highly-specific regulation of gene expression. 
To design a synthetic promoter it is essential to identify an appropriate number of cis-
regulatory elements that can specifically bind to the trans factors that enhance gene 
transcription. This is where the importance of a number of bioinformatic algorithms 
becomes apparent. Over the past several years a number of databases and programs have 
been developed in order to identify transcription factor biding sites (TFBSs) on a variety of 
genomes. Below we introduce the most extensively used resources and discuss their 
application to the design of synthetic promoters, we pay particular attention to the 
identification of transcription networks active in cancer and how this information can be 
used to design cancer-specific promoters that can be used in the design of safer and more 
effective tumour-targeted gene therapies. 
There is now a growing trend for researchers to analyse microarray data in terms of ‘gene 
modules’ instead of the presentation of differentially regulated gene lists. By grouping genes 
into functionally related modules it is possible to identify subtle changes in gene expression 
that may be biologically (if not statistically significantly) important, to more easily interpret 
molecular pathways that mediate a particular response and to compare many different 
microarray experiments from different disease states in an effort to uncover the 
commonalities and differences in multiple clinical conditions. Therefore, we are moving into 
a new era of functional genomics, where the large datasets generated by the evaluation of 
global gene expression studies can be more fully interpreted by improvements in 
computational methods. The advances in functional genomics made in recent years have 
resulted in the identification of many more cis-regulatory elements that can be directly 
related to the increased transcription of specific genes. Indeed, the ability to use 
bioinformatics to unravel complex transcriptional pathways active in diseased cells can 
actually serve to facilitate the process of choosing suitable cis-elements that can be used to 
design synthetic promoters specifically active in complex pathologies such as cancer. 
In cancer the changes in the gene expression profile are often the result of alterations in the 
cell’s transcription machinery induced by aberrant activation of signalling pathways that 
control growth, proliferation and migration. Such changes result in the activation of 
transcription regulatory networks that are not found in normal cells and provide us with an 
opportunity to design synthetic promoters that should only be active in cancerous cells. If 
microarray technology is to truly result in the design of tailored therapies to individual 
cancers or even patients, as has been heralded, it is important that the functional genomics 
methodology that was designed for the identification of signalling and transcription 
networks be applied to the design of cancer-specific promoters so that effective gene 
therapeutic strategies can be formulated (Roberts & Kottaridis, 2007). The development of 
bioinformatics algorithms for the analysis of microarray datasets has largely been applied in 
order to unravel the transcription networks operative under different disease and 
environmental conditions. To this date there has been no effort to use this type of approach 
to design synthetic promoters that are operative only under these certain disease or 
environmental conditions. 
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The regulation of gene expression in eukaryotes is highly complex and often occurs through 
the coordinated action of multiple transcription factors. The use of trans-factor combinations 
in the control of gene expression allows a cell to employ a relatively small number of 
transcription factors in the regulation of disparate biological processes. As discussed herein, 
a number of tools have been developed that allow us to utilise microarray data to identify 
novel cis-regulatory elements. It is also possible to use this information to decipher the 
transcriptional networks that are active in cells under different environmental conditions. In 
yeast, the importance of the combinatorial nature of transcriptional regulation was 
established by specifically examining clusters of upregulated genes for the presence of 
combinations of cis-elements. By examining microarray data from yeast exposed to a variety 
of conditions the authors were able to construct a network of transcription revealing the 
functional associations between different regulatory elements. This approach resulted in the 
identification of key motifs with many interactions, suggesting that some factors serve as 
facilitator proteins assisting their gene-specific partners in their function. The idea that a 
core number of transcription factors mediate such a vast array of biological responses by 
adopting multiple configurations implies that it may be possible to hijack the transcriptional 
programs that have gone awry in multifactorial diseases in an effort to develop disease-
specific regulatory elements. For instance, the meta-analyses of cancer datasets has 
permitted the identification of gene modules, allowing for the reduction of complex cancer 
signatures to small numbers of activated transcription programs and even to the 
identification of common programs that are active in most types of cancer. This type of 
analysis can also help to identify specific transcription factors whose deregulation plays a 
key role in tumour development. In one such study, the importance of aberrant E2F activity 
in cancer was reaffirmed during a search for the regulatory programs linking transcription 
factors to the target genes found upregulated in specific cancer types (Rhodes et al., 2005). It 
was shown that E2F target genes were disproportionately upregulated in more than half of 
the gene expression profiles examined, which were obtained from a multitude of different 
cancer types. It was thus proposed that integrative bioinformatics analyses have the 
potential to generate new hypotheses about cancer progression. 
Different bioinformatics tools, examples of which are given in table 1, may be used to screen 
for cis-regulatory elements. In general, such tools function by comparing gene expression 
profiles between differentially regulated genes and examining upstream sequences, 
available through genome sequence resources. For the phylogenetic footprinting tools, the 
untranslated regions of specific genes are compared between species and the most highly 
conserved sequences are returned and proposed to be potential cis-elements. A combination 
of all available approaches may be employed in order to identify regulatory sequences that 
predominate in the profile of specific cell or tissue types. The most common sequences 
identified are then used as the building blocks employed in the design of synthetic 
promoters. 
The ability to use gene expression data to identify gene modules, which mediate specific 
responses to environmental stimuli (or to a diseased state) and to correlate their regulation 
to the cis-regulatory elements present upstream of the genes in each module, has 
transformed the way in which we interpret microarray data. For instance, by using the 
modular approach it is possible to examine whether particular gene modules are active in a 
variety of different cancers, or whether individual cancers require the function of unique 
gene modules. This has allowed us to look for transcriptional commonalities between 
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different cancers, which should aid in the design of widely applicable anti-cancer 
therapeutic strategies. In one early study, gene expression data from 1975 microarrays, 
spanning 22 different cancers was used to identify gene modules that were activated or 
deactivated in specific types of cancer (Segal et al., 2004). Using this approach the authors 
found that a bone osteoblastic module was active in a number of cancers whose primary 
metastatic site is known to be the bone. Thus, a common mechanism of bone metastasis 
between varieties of different cancers was identified, which could be targeted in the 
development of novel anticancer therapies. 
It is also possible to identify the higher-level regulator that controls the expression of the 
genes in each module (Segal et al., 2003). Examination of the upstream regulatory sequences 
of each gene in a module may reveal the presence of common cis-regulatory elements that 
are known to be the target of the module’s regulator. Therefore, by identifying specific 
regulatory proteins that control the activation of gene modules in different cancers, it should 
be possible to extrapolate the important cis-elements that mediate transcription in the 
transformed cell. Thereby, allowing us to design and construct novel tumour-specific 
promoters based on the most active cis-regulatory elements in a number of tumour-specific 
gene modules. The ability to identify specific transcriptional elements in the human genome 
that control the expression of functionally related genes is transforming the application of 
functional genomics. Until recently the interpretation of data from microarray analysis has 
been limited to the identification of genes whose function may be important in a single 
pathway or response. How this related to global changes in the cellular phenotype had been 
largely ignored, as the necessary tools to examine this simply did not exist. With the 
advancement of bioinformatics we are now in a position to utilise all the data that is 
obtained from large-scale gene expression analysis and combine it with knowledge of the 
completed sequence of the human genome and with transcription factor, gene ontology and 
molecular function databases, thereby more fully utilising the large datasets that are 
generated by global gene expression studies. 
For nearly two decades scientists have been compiling databases that catalogue the trans-
factors and cis-elements that are responsible for gene regulation (Wingender et al., 1988). 
This has primarily been done in an effort to elucidate the various transcription programs 
that are activated in response to different biological stimuli in a range of organisms. The 
result is the emergence of useful tools that can be used to identify transcription factors and 
their corresponding cis-regulatory sequences that are useful in the design of synthetic 
promoters. In the remaining part of this chapter we briefly discuss each resource, indicating 
the unique aspect of its functionality. 
TRANSFAC is perhaps the most comprehensive TFBS database available and indexes 
transcription factors and their target sequences based solely on experimental data (Matys et 
al., 2003). It is maintained as a relational database, from which public releases are made 
available via the web. The release consists of six flat files. At the core of the database is the 
interaction of transcription factors (FACTOR) with their DNA-binding sites (SITE) through 
which they regulate their target genes (GENE). Apart from genomic sites, ‘artificial’ sites 
which are synthesized in the laboratory without any known connection to a gene, e.g., 
random oligonucleotides, and IUPAC consensus sequences are also stored in the SITE table. 
Sites must be experimentally proven for their inclusion in the database. Experimental 
evidence for the interaction with a factor is given in the SITE entry in form of the method 
that was used (gel shift, footprinting analysis, etc.) and the cell from which the factor was 
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derived (factor source). The latter contains a link to the respective entry in the CELL table. 
On the basis of those, method and cell, a quality value is given to describe the ‘confidence’ 
with which an observed DNA- binding activity could be assigned to a specific factor. From a 
collection of binding sites for a factor nucleotide weight matrices are derived (MATRIX). 
These matrices are used by the tool MatchTM to find potential binding sites in 
uncharacterized sequences, while the program PatchTM uses the single site sequences, which 
are stored in the SITE table. According to their DNA-binding domain transcription factors 
are assigned to a certain class (CLASS). In addition to the more ‘planar’ CLASS table a 
hierarchical factor classification system is also used. 
TRANSCompel® originates from COMPEL, and functions to emphasize the key role of 
specific interactions between transcription factors binding to their target cis-regulatory 
elements; whilst providing specific features of gene regulation in a particular cellular 
content (Kel-Margoulis et al., 2002). Information about the structure of known trans factor 
and cis sequence interactions, and specific gene regulation achieved through these 
interactions, is extremely useful for promoter prediction. In the TRANSCompel database, 
each entry corresponds to an individual trans/cis interaction within the context of a 
particular gene and thus contains information about two binding sites, two corresponding 
transcription factors and experiments confirming cooperative action between transcription 
factors. 
ABS is a public database of known cis-regulatory binding sites identified in promoters of 
orthologous vertebrate genes that have been manually collated from the scientific literature 
(Blanco et al., 2006). In this database some 650 experimental binding sites from 68 
transcription factors and 100 orthologous target genes in human, mouse, rat or chicken 
genome sequences have been documented. This tool allows computational predictions and 
promoter alignment information for each entry and is accessed through a simple and easy-
to-use web interface; facilitating data retrieval and allowing different views of the 
information. One of the key features of this software is the inclusion of a customizable 
generator of artificial datasets based on the known sites contained in the whole collection 
and an evaluation tool to aid during the training and the assessment of various motif-
finding programs. 
JASPAR is an open-access database of annotated, high-quality, matrix-based TFBS profiles 
for multi-cellular eukaryotic organisms (Sandelin et al., 2004). The profiles were derived 
exclusively from sets of nucleotide sequences that were experimentally demonstrated to 
bind transcription factors. The database is accessible via a web-interface for browsing, 
searching and subset selection. The interface also includes an online sequence analysis 
utility and a suite of tools for genome-wide and comparative genome analysis of regulatory 
regions. 
HTPSELEX is a public database providing access to primary and derived data from high-
throughput SELEX experiments that were specifically designed in order to characterize the 
binding specificity of transcription factors (Jagannathan et al., 2006). The resource is 
primarily intended to serve computational biologists interested in building models of TFBSs 
from large sets of cis-regulatory sequences. For each experiment detailed in the database 
accurate information is provided about the protein material used, details of the wet lab 
protocol, an archive of sequencing trace files, assembled clone sequences and complete sets 
of in vitro selected protein-binding tags. 
www.intechopen.com
 
Computational Biology and Applied Bioinformatics 
 
386 
TRED is a database that stores both cis- and trans-regulatory elements and was designed to 
facilitate easy data access and to allow for the analysis of single-gene-based and genome- 
scale studies (Zhao et al., 2005). Distinguishing features of TRED include: relatively 
complete genome-wide promoter annotation for human, mouse and rat; availability of gene 
transcriptional regulation information including TFBSs and experimental evidence; data 
accuracy is ensured by hand curation; efficient user interface for easy and flexible data 
retrieval; and implementation of on-the-fly sequence analysis tools. TRED can provide good 
training datasets for further genome-wide cis-regulatory element prediction and annotation; 
assist detailed functional studies and facilitate the deciphering of gene regulatory networks. 
Databases of known TFBSs can be used to detect the presence of protein-recognition 
elements in a given promoter, but only when the binding site of the relevant DNA-binding 
protein and its tolerance to mismatches in vivo is already known. Because this knowledge is 
currently limited to a small subset of transcription factors, much effort has been devoted to 
the discovery of regulatory motifs by comparative analysis of the DNA sequences of 
promoters. By finding conserved regions between multiple promoters, motifs can be 
identified with no prior knowledge of TFBSs. A number of models have emerged that 
achieve this by statistical overrepresentation. These algorithms function by aligning 
multiple untranslated regions from the entire genome and identifying sequences that are 
statistically significantly overrepresented in comparison to what it expected by random. 
YMF is a program developed to identify novel TFBSs (not necessarily associated with a 
specific factor) in yeast by searching for statistically overrepresented motifs (Sinha et al., 
2003; Sinha & Tompa, 2002). More specifically, YMF enumerates all motifs in the search 
space and is guaranteed to produce those motifs with the greatest z-scores. 
SCORE is a computational method for identifying transcriptional cis-regulatory modules 
based on the observation that they often contain, in statistically improbable concentrations, 
multiple binding sites for the same transcription factor (Rebeiz et al., 2002). Using this 
method the authors conducted a genome-wide inventory of predicted binding sites for the 
Notch-regulated transcription factor Suppressor of Hairless, Su(H), in drosophila and found 
that the fly genome contains highly non-random clusters of Su(H) sites over a broad range 
of sequence intervals. They found that the most statistically significant clusters were very 
heavily enriched in both known and logical targets of Su(H) binding and regulation. The 
utility of the SCORE approach was validated by in vivo experiments showing that proper 
expression of the novel gene Him in adult muscle precursor cells depends both on Su(H) 
gene activity and sequences that include a previously unstudied cluster of four Su(H) sites, 
indicating that Him is a likely direct target of Su(H). 
At present these tools are mainly applied in the study of lower eukaryotes where the 
genome is less complex and regulatory elements are easier to identify, extending these 
algorithms to the human genome has proven somewhat more difficult. In order to redress 
this issue a number of groups have shown that it is possible to mine the genome of higher 
eukaryotes by searching for conserved regulatory elements adjacent to transcription start 
site motifs such as TATA and CAAT boxes, e.g. as catalogued in the DBTSS resource 
(Suzuki et al. 2004; Suzuki et al., 2002), or one can search for putative cis-elements in CpG 
rich regions that are present in higher proportions in promoter sequences (Davuluri et al., 
2001). Alternatively, with the co-emergence of microarray technology and the complete 
sequence of the human genome, it is now possible to search for potential TFBSs by 
comparing the upstream non-coding regions of multiple genes that show similar expression 
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profiles under certain conditions. Gene sets for comparative analysis can be chosen based on 
clustering, e.g. hierarchical and k-means (Roth et al., 1998), from simple expression ratio 
(Bussemaker et al., 2001) or functional analysis of gene products (Jensen et al., 2000). This 
provides scientists with the opportunity to identify promoter elements that are responsive to 
certain environmental conditions, or those that play a key role in mediating the 
differentiation of certain tissues or those that may be particularly active in mediating 
pathologic phenotypes. 
Phylogenetic footprinting, or comparative genomics, is now being applied to identify novel 
promoter elements by comparing the evolutionary conserved untranslated elements 
proximal to known genes from a variety of organisms. The availability of genome sequences 
between species has notably advanced comparative genomics and the understanding of 
evolutionary biology in general. The neutral theory of molecular evolution provides a 
framework for the identification of DNA sequences in genomes of different species. Its 
central hypothesis is that the vast majority of mutations in the genome are neutral with 
respect to the fitness of an organism. Whilst deleterious mutations are rapidly removed by 
selection, neutral mutations persist and follow a stochastic process of genetic drift through a 
population. Therefore, non-neutral DNA sequences (functional DNA sequences) must be 
conserved during evolution, whereas neutral mutations accumulate. Initial studies 
sufficiently demonstrated that the human genome could be adequately compared to the 
genomes of other organisms allowing for the efficient identification of homologous regions 
in functional DNA sequences. 
Subsequently, a number of bioinformatics tools have emerged that operate by comparing 
non-coding regulatory sequences between the genomes of various organisms to enable the 
identification of conserved TFBSs that are significantly enriched in promoters of candidate 
genes or from clusters identified by microarray analysis; examples of these software suites 
are discussed below. Typically these tools work by aligning the upstream sequences of 
target genes between species thus identifying conserved regions that could potentially 
function as cis-regulatory elements and have consequently been applied in the elucidation of 
transcription regulatory networks in a variety of models. 
TRAFAC is a Web-based application for analysis and display of a pair of DNA sequences 
with an emphasis on the detection of conserved TFBSs (Jegga et al., 2002). A number of 
programs are used to analyze the sequences and identify various genomic features (for 
example, exons, repeats, conserved regions, TFBSs). Repeat elements are masked out using 
RepeatMasker and the sequences are aligned using the PipMaker-BLASTZ algorithm. 
MatInspector Professional or Match (BioBase) is run to scan the sequences for TFBSs. TRAFAC 
then integrates analysis results from these applications and generates graphical outputs; 
termed the Regulogram and Trafacgram. 
CORG comprises a catalogue of conserved non-coding sequence blocks that were initially 
computed based on statistically significant local suboptimal alignments of 15kb regions 
upstream of the translation start sites of some 10793 pairs of orthologous genes (Dieterich et 
al., 2003). The resulting conserved non-coding blocks were annotated with EST matches for 
easier detection of non-coding mRNA and with hits to known TFBSs. CORG data are 
accessible from the ENSEMBL web site via a DAS service as well as a specially developed 
web service for query and interactive visualization of the conserved blocks and their 
annotation. 
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CONSITE is a flexible suite of methods for the identification and visualization of conserved 
TFBSs (Lenhard et al., 2003). The system reports those putative TFBSs that are both situated 
in conserved regions and located as pairs of sites in equivalent positions in alignments 
between two orthologous sequences. An underlying collection of metazoan transcription-
factor-binding profiles was assembled to facilitate the study. This approach results in a 
significant improvement in the detection of TFBSs because of an increased signal-to-noise 
ratio, as as the authors demonstrated with two sets of promoter sequences. 
CONFAC enables the high-throughput identification of conserved TFBSs in the regulatory 
regions of hundreds of genes at a time (Karanam et al., (2004). The CONFAC software 
compares non-coding regulatory sequences between human and mouse genomes to enable 
identification of conserved TFBSs that are significantly enriched in promoters of gene 
clusters from microarray analyses compared to sets of unchanging control genes using a 
Mann–Whitney statistical test. The authors analysed random gene sets and demonstrated 
that using this approach, over 98% of TFBSs had false positive rates below 5%. As a proof-
of-principle, the CONFAC software was validated using gene sets from four separate 
microarray studies and TFBSs were identified that are known to be functionally important 
for regulation of each of the four gene sets. 
VAMP is a graphical user interface for both visualization and primary level analysis of 
molecular profiles obtained from functional genomics experimentation (La Rosa et al., 2006). 
It can be applied to datasets generated from Comparative Genomic Hybridisation (CGH) 
arrays, transcriptome arrays, Single Nucleotide Polymorphism arrays, loss of heterozygosity 
analysis (LOH), and Chromatin Immunoprecipitation experiments (ChIP-on-chip). The 
interface allows users to collate the results from these different types of studies and to view 
it in a convenient way. Several views are available, such as the classical CGH karyotype 
view or genome-wide multi-tumour comparisons. Many of the functionalities required for 
the analysis of CGH data are provided by the interface; including searches for recurrent 
regions of alterations, comparison to transcriptome data, correlation to clinical information, 
and the ability to view gene clusters in the context of genome structure. 
CisMols Analyser allows for the filtering of candidate cis-element clusters based on 
phylogenetic conservation across multiple gene sets (Jegga et al., 2005). It was previously 
possible to achieve this for individual orthologue gene pairs, but combining data from cis-
conservation and coordinate expression across multiple genes proved a more difficult task. 
To address this issue, the authors extended an orthologue gene pair database with 
additional analytical architecture to allow for the analysis and identification of maximal 
numbers of compositionally similar and phylogenetically conserved cis-regulatory element 
clusters from a list of user-selected genes. The system has been successfully tested with a 
series of functionally related and microarray profile-based co-expressed orthologue pairs of 
promoters and genes using known regulatory regions as training sets and co-expressed 
genes in the olfactory and immunohematologic systems as test sets. A significant amount of 
effort has been dedicated to the cataloguing of transcription factors and their corresponding 
cis-elements. More recently, these databases have been compiled with the aim to utilise them 
to unravel regulatory networks active in response to diverse stimuli. 
PreMod was developed in an effort to identify cis-regulatory modules (CRM) active under 
specific environmental conditions (Blanchette et al., 2006; Ferretti et al., 2007). Starting from 
a set of predicted binding sites for more than 200 transcription factor families documented 
in the Transfac database (described above), the authors describe an algorithm relying on the 
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principle that cis-regulatory modules (CRMs) generally contain several phylogenetically 
conserved binding sites for a small variety of transcription factors. The method allowed the 
prediction of more than 118,000 CRMs within the human genome. During this analysis, it 
was revealed that CRM density varies widely across the genome, with CRM-rich regions 
often being located near genes encoding transcription factors involved in development. 
Interestingly, in addition to showing enrichment near the 3’ end of genes, predicted CRMs 
were present in other regions more distant from genes. In this database, the tendency for 
certain transcription factors to bind modules located in specific regions was documented 
with respect to their target genes, and a number of transcription factors likely to be involved 
in tissue-specific regulation were identified. 
CisView was developed to facilitate the analysis of gene regulatory regions of the mouse 
genome (Sharov et al., 2006). Its user interface is a browser and database of genome-wide 
potential TFBSs that were identified using 134 position-weight matrices and 219 sequence 
patterns from various sources. The output is presented with information about sequence 
conservation, neighbouring genes and their structures, GO annotations, protein domains, 
DNA repeats and CpG islands. The authors used this tool to analyse the distribution of 
TFBSs and revealed that many TFBSs were over-represented near transcription start sites. In 
the initial paper presenting the tool they also identified potential cis-regulatory modules 
defined as clusters of conserved TFBSs in the entire mouse genome. Out of 739,074 CRMs 
identified, 157,442 had a significantly higher regulatory potential score than semi-random 
sequences. The CisView browser provides a user-friendly computer environment for 
studying transcription regulation on a whole-genome scale and can also be used for 
interpreting microarray experiments and identifying putative targets of transcription 
factors. 
BEARR is web browser software designed to assist biologists in efficiently carrying out the 
analysis of microarray data from studies of specific transcription factors (Vega et al., 2004). 
Batch Extraction and Analysis of cis-Regulatory Regions, or BEARR, accepts gene identifier 
lists from microarray data analysis tools and facilitates identification, extraction and analysis 
of regulatory regions from the large amount of data that is typically generated in these types 
of studies. 
VISTA is a family of computational tools that was built to assist in the comparative analysis 
of DNA sequences (Dubchak & Ryaboy, 2006). These tools allow for the alignment of DNA 
sequences to facilitate the visualization of conservation levels and thus allow for the 
identification of highly conserved regions between species. Specifically, sequences can be 
analysed by browsing through pre-computed whole-genome alignments of vertebrates and 
other groups of organisms. Submission of sequences to Genome VISTA enables the user to 
align them to other whole genomes; whereas submission of two or more sequences to 
mVISTA allows for direct alignment. Submission of sequences to Regulatory VISTA is also 
possible and enables the predication of potential TFBSs (based on conservation within 
sequence alignments). All VISTA tools use standard algorithms for visualization and 
conservation analysis to make comparison of results from different programs more 
straightforward. 
PromAn is a modular web-based tool dedicated to promoter analysis that integrates a 
number of different complementary databases, methods and programs (Lardenois et al., 
2006). PromAn provides automatic analysis of a genomic region with minimal prior 
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knowledge of the genomic sequence. Prediction programs and experimental databases are 
combined to locate the transcription start site (TSS) and the promoter region within a large 
genomic input sequence. TFBSs can be predicted using several public databases and user-
defined motifs. Also, a phylogenetic footprinting strategy, combining multiple alignments of 
large genomic sequences and assignment of various scores reflecting the evolutionary 
selection pressure, allows for evaluation and ranking of TFBS predictions. PromAn results 
can be displayed in an interactive graphical user interface. It integrates all of this 
information to highlight active promoter regions, to identify among the huge number of 
TFBS predictions those which are the most likely to be potentially functional and to facilitate 
user refined analysis. Such an integrative approach is essential in the face of a growing 
number of tools dedicated to promoter analysis in order to propose hypotheses to direct 
further experimental validations. 
CRSD is a comprehensive web server that can be applied in investigating complex 
regulatory behaviours involving gene expression signatures, microRNA regulatory 
signatures and transcription factor regulatory signatures (Liu et al., 2006). Six well-known 
and large-scale databases, including the human UniGene, mature microRNAs, putative 
promoter, TRANSFAC, pathway and Gene Ontology (GO) databases, were integrated to 
provide the comprehensive analysis in CRSD. Two new genome-wide databases, of 
microRNA and transcription factor regulatory signatures were also constructed and further 
integrated into CRSD. To accomplish the microarray data analysis at one go, several 
methods, including microarray data pre-treatment, statistical and clustering analysis, 
iterative enrichment analysis and motif discovery, were closely integrated in the web server. 
MPromDb is a database that integrates gene promoters with experimentally supported 
annotation of transcription start sites, cis-regulatory elements, CpG islands and chromatin 
immunoprecipitation microarray (ChIP-chip) experimental results within an intuitively 
designed interface (Sun et al., 2006). Its initial release contained information on 36,407 
promoters and first exons, 3,739 TFBSs and 224 transcription factors; with links to PubMed 
and GenBank references. Target promoters of transcription factors that have been identified 
by ChIP-chip assay are also integrated into the database and thus serving as a portal for 
genome-wide promoter analysis of data generated by ChIP-chip experimental studies. 
A comprehensive list of the all the databases described above with a summary of their 
features and a reference to the original citation are shown in table 1. 
Each of the aforementioned databases can be used when searching for potential regulatory 
sequences for inclusion in the design of synthetic promoters. Indeed, these resources can be 
used in order to identify cis-regulatory elements that may play a role in the formation of a 
particular cellular phenotype, or those that may be important in driving differentiation in 
developing organs. Synpromics, an emerging synthetic biology company recently 
incorporated in the United Kingdom, has cleverly utilised these tools in developing a 
proprietary method of synthetic promoter production where identified elements are 
incorporated into the design of promoters that are able to specifically regulate gene 
expression in a particular cellular phenotype. This method harnesses a cell’s gene expression 
profile in order to facilitate the design of highly specific and efficient promoters. The result 
is a range of promoters that are inducible, tissue (or cell)-specific, active in response to a 
particular pathogen, chemical or biological agent and even able to mediate gene expression 
only under certain pathological conditions, such as cancer. Indeed, Synpromics has 
successfully generated a range of synthetic promoters that specifically drive high levels of 
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gene expression in colorectal cancer and are looking to apply these promoters in the 
development of safer gene therapies (manuscript in preparation).  
 
Resource Description Citation 
DBTSS Database of transcriptional start sites Suzuki et al., (2002) 
TRAFAC Conserved cis-element search tool Jegga et al., (2002) 
TRANSCom
pel 
Database of composite regulatory elements Kel-Margoulis et al., 
(2002) 
TRANSFAC Eukaryotic transcription factor database Matys et al., (2003) 
Phylofoot Tools for phylogenetic footprinting purposes Lenhard et al., (2003) 
CORG Multi-species DNA comparison and annotation Dieterich et al., (2003) 
CONSITE Explores trans-factor binding sites from two species Lenhard et al., (2003) 
CONFAC Conserved TFBS finder Karanam et al., (2004) 
CisMols Identifies cis-regulatory modules from inputed data Jegga et al., (2005) 
TRED  Catalogue of transcription regulatory elements Zhao et al., (2005) 
Oncomine Repository and analysis of cancer microarray data Rhodes et al., (2005) 
ABS Database of regulatory elements Blanco et al., (2006) 
JASPAR Database of regulatory elements Sandelin et al., (2004) 
HTPSELEX Database of composite regulatory elements Jagannathan et al., 
(2006) 
PReMod Database of transcriptional regulatory modules in the 
human genome 
Blanchette et al., 
(2006) 
CisView Browser of regulatory motifs and regions in the 
genome 
Sharov et al., (2006) 
BEARR Batch extraction algorithm for microarray data analysis Vega et al., 2004) 
VISTA Align and compare sequences from multiple species Dubchak et al., (2006) 
PromAn Promoter analysis by integrating a variety of databases Lardenois et al., 
(2006) 
Table 1. Bioinformatics tools used for the identification of cis-regulatory elements 
Importantly, synthetic promoters often mediate a level of gene expression with much 
greater efficiency than that seen with viral promoters, such as CMV, or compared to 
naturally occurring promoters within the genome. Given that the entire Biotech industry is 
centred on the regulation of gene expression, it is likely that synthetic promoters will 
eventually replace all naturally-occurring sequences in use today and help drive the growth 
of the synthetic biology sector in the coming decades. 
6. Conclusion 
In summary, synthetic promoters have emerged over the past two decades as excellent tools 
facilitating the identification of important structural features in naturally occurring 
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promoter sequences and allowing enhanced and more restrictive regulation of gene 
expression. A number of early studies revealed that it was possible to combine the cis-
regulatory elements from promoters of a few tissue-specific genes and use these as building 
blocks to generate shorter, more efficient tissue-specific promoters. Several simple 
methodologies to achieve this emerged and have been applied in a multitude of organisms; 
including plant, bacteria, yeast, viral and mammalian systems. 
Recent advances in bioinformatics and the emergence of a plethora of tools specifically 
designed at unravelling transcription programs has also facilitated the design of highly-
specific synthetic promoters that can drive efficient gene expression in a tightly regulated 
manner. Changes in a cell’s gene expression profile can be monitored and the transcription 
programs underpinning that change delineated and the corresponding cis-regulatory 
modules can be used to construct synthetic promoters whose activity is restricted to 
individual cell types, or to single cells subject to particular environmental conditions. This 
has allowed researchers to design promoters that are active in diseased cells or in tissues 
treated with a particular biological or chemical agent; or active in cells infected with distinct 
pathogens. 
A number of institutions, such as Synpromics, have taken advantage of these advances and 
are now working to apply synthetic promoter technology to the enhanced production of 
biologics for use in biopharmaceutical, greentech and agricultural applications; the 
development of new gene therapies; and in the design of a novel class of molecular 
diagnostics. As the synthetic biology field continues to develop into a multi-billion dollar 
industry, synthetic promoter technology is likely to remain at the heart of this ever-
expanding and exciting arena. 
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